Clinical Trial Update: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating dexmedetomidine (Precedex) for severe alcohol withdrawal syndrome and alcohol withdrawal delirium was terminated. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Delirium
• Alcohol Withdrawal Hallucinosis
• Alcohol Withdrawal Syndrome
• Delirium Tremens

Drugs mentioned

• PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: Denver Health and Hospital Authority | Conditions: Alcohol Withdrawal Delirium, Alcohol Withdrawal Associated Autonomic Hyperactivity | Phase 4 | Status: TERMINATED | Results posted: 2017-07-17